K. Nicholson, J. Wood, and M. Zambon, Influenza, The Lancet, vol.362, issue.9397, pp.1733-1745, 2003.
DOI : 10.1016/S0140-6736(03)14854-4

R. Webby and R. Webster, Are we ready for pandemic influenza? Science, pp.1519-1522, 2003.

T. Francis, Vaccination against influenza. Bull World Health Organ, pp.725-741, 1953.

M. Hilleman, Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control, Vaccine, vol.20, issue.25-26, pp.3068-3087, 2002.
DOI : 10.1016/S0264-410X(02)00254-2

S. Tamura, T. Tanimoto, and T. Kurata, Mechanisms of broad crossprotection provided by influenza virus infection and their application to vaccines, Jpn J Infect Dis, vol.58, pp.195-207, 2005.

E. Check, Avian flu special: Is this our best shot?, Nature, vol.363, issue.7041, pp.404-406, 2005.
DOI : 10.1038/435404a

E. Hoffmann, S. Krauss, D. Perez, R. Webby, and R. Webster, Eight-plasmid system for rapid generation of influenza virus vaccines, Vaccine, vol.20, issue.25-26, pp.3165-3170, 2002.
DOI : 10.1016/S0264-410X(02)00268-2

M. Ohuchi, A. Cramer, M. Vey, R. Ohuchi, W. Garten et al., Rescue of vector expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein, J Virol, vol.68, pp.920-926, 1994.

P. Puthavathana, P. Auewarakul, P. Charoenying, K. Sangsiriwut, P. Pooruk et al., Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand, Journal of General Virology, vol.86, issue.2, pp.423-433, 2005.
DOI : 10.1099/vir.0.80368-0

A. Amonsin, S. Payungporn, A. Theamboonlers, R. Thanawongnuwech, S. Suradhat et al., Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand, Virology, vol.344, issue.2, pp.480-491, 2006.
DOI : 10.1016/j.virol.2005.08.032

J. Skehel and D. Wiley, Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin, Annual Review of Biochemistry, vol.69, issue.1, pp.531-569, 2000.
DOI : 10.1146/annurev.biochem.69.1.531

D. Bucher and P. Palese, The biologically active proteins of influenza virus: neuraminidase. In The influenza viruses and influenza Edited by: Kilbourne ED, pp.83-123

M. Matrosovich, T. Matrosovich, T. Gray, N. Roberts, and H. Klenk, Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium, Journal of Virology, vol.78, issue.22, pp.12665-12667, 2004.
DOI : 10.1128/JVI.78.22.12665-12667.2004

R. Lamb, L. Holsinger, and L. Pinto, The influenza A virus M2 ion channel protein and its role in the influenza virus life cycle, Cellular receptors of animal viruses Edited by: Wimmer E. Cold Spring Harbor, pp.303-321

A. Hay, The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein, Semin Virol, vol.3, pp.21-30, 1992.

T. Hatziioannou, S. Valsesia-wittmann, S. Russell, and F. Cosset, Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses, J Virol, vol.72, pp.5313-5317, 1998.

V. Sandrin, B. Boson, P. Salmon, W. Gay, D. Nègre et al., Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates, Blood, vol.100, issue.3, pp.823-832, 2002.
DOI : 10.1182/blood-2001-11-0042

V. Sandrin and F. Cosset, Intracellular Versus Cell Surface Assembly of Retroviral Pseudotypes Is Determined by the Cellular Localization of the Viral Glycoprotein, Its Capacity to Interact with Gag, and the Expression of the Nef Protein, Journal of Biological Chemistry, vol.281, issue.1, pp.528-542, 2006.
DOI : 10.1074/jbc.M506070200

J. Szecsi, R. Drury, V. Josserand, M. Grange, B. Boson et al., Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA???protease interactions, Molecular Therapy, vol.14, issue.5, 2006.
DOI : 10.1016/j.ymthe.2006.04.007

URL : https://hal.archives-ouvertes.fr/inserm-00176685

B. Bellier, C. Dalba, B. Clerc, D. Desjardins, R. Drury et al., DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant, Vaccine, vol.24, issue.14, pp.2643-2655, 2006.
DOI : 10.1016/j.vaccine.2005.11.034

B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson et al., Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor, Journal of Biological Chemistry, vol.278, issue.43, pp.41624-41630, 2003.
DOI : 10.1074/jbc.M305289200

D. Negre, P. Mangeot, G. Duisit, S. Blanchard, P. Vidalain et al., Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells, Gene Therapy, vol.7, issue.19, pp.1613-1623, 2000.
DOI : 10.1038/sj.gt.3301292

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893

URL : https://hal.archives-ouvertes.fr/inserm-00133783

B. Bartosch, J. Bukh, J. Meunier, C. Granier, R. Engle et al., In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences, vol.289, issue.5487, pp.14199-14204, 2003.
DOI : 10.1126/science.289.5487.2003a

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, yours ? you keep the copyright Submit your manuscript here, pp.6023-603470, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

V. Bosch, B. Kramer, T. Pfeiffer, L. Starck, and D. Steinhauer, Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors, Journal of General Virology, vol.82, issue.10, pp.2485-2494, 2001.
DOI : 10.1099/0022-1317-82-10-2485

T. Mckay, M. Patel, R. Pickles, L. Johnson, and J. Olsen, Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors, Gene Therapy, vol.88, issue.8, pp.715-724, 2006.
DOI : 10.1038/sj.gt.3302715

J. Skehel, P. Bayley, E. Brown, S. Martin, M. Waterfield et al., Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion., Proceedings of the National Academy of Sciences, vol.79, issue.4, pp.968-972, 1982.
DOI : 10.1073/pnas.79.4.968

P. Graves, J. Schulman, J. Young, and P. Palese, Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: Unmasking of cross-reactive HA2 determinants, Virology, vol.126, issue.1, pp.106-116, 1983.
DOI : 10.1016/0042-6822(83)90465-8

H. Sagawa, A. Ohshima, I. Kato, Y. Okuno, and Y. Isegawa, The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region, Journal of General Virology, vol.77, issue.7, pp.771483-1487, 1996.
DOI : 10.1099/0022-1317-77-7-1483

Y. Okuno, Y. Isegawa, F. Sasao, and S. Ueda, A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains, J Virol, vol.67, pp.2552-2558, 1993.

Q. Yao, F. Kuhlmann, R. Eller, R. Compans, and C. Chen, Production and Characterization of Simian-Human Immunodeficiency Virus-Like Particles, AIDS Research and Human Retroviruses, vol.16, issue.3, pp.227-236, 2000.
DOI : 10.1089/088922200309322

G. Duisit, A. Salvetti, P. Moullier, and F. Cosset, Functional Characterization of Adenoviral/Retroviral Chimeric Vectors and Their Use for Efficient Screening of Retroviral Producer Cell Lines, Human Gene Therapy, vol.10, issue.2, pp.189-200, 1999.
DOI : 10.1089/10430349950018986

M. Roberts, D. Wells, I. Graham, S. Fabb, V. Hill et al., Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle, Human Molecular Genetics, vol.11, issue.15, pp.1719-1730, 2003.
DOI : 10.1093/hmg/11.15.1719

N. Savard, F. Cosset, and A. Epstein, Use of defective HSV-1 vectors harbouring gag, pol, and env genes to rescue defective retrovirus vectors, J Virol, vol.71, pp.4111-4117, 1997.